Herbalife Ltd. Common Shares (HLF)

12.34
-0.05 (-0.40%)
NYSE· Last Trade: Aug 27th, 11:13 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Herbalife Maps Growth Plan With APAC Momentum, Margin Expansion and Debt Reductionmarketbeat.com
Herbalife (NYSE:HLF) outlined its strategy for returning to growth, expanding margins and reducing debt during a presentation at the Midwest IDEAS Conference, with incoming Chief Financial Officer Scott Schaefer highlighting growth in active sales leaders, regional momentum in Asia-Pacific and Latin
Via MarketBeat · August 26, 2026
1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Find Risky
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Via StockStory · August 25, 2026
Q2 Rundown: Herbalife (NYSE:HLF) Vs Other Personal Care Stocks
Let’s dig into the relative performance of Herbalife (NYSE:HLF) and its peers as we unravel the now-completed Q2 personal care earnings season. While persona...
Via StockStory · August 20, 2026
1 Russell 2000 Stock with Competitive Advantages and 2 We Turn Down
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...
Via StockStory · August 20, 2026
Herbalife (NYSE:HLF) Falls After Q2 Earnings Miss Offsets Revenue Growthchartmill.com
Via Chartmill · August 5, 2026
3 Profitable Stocks with Questionable Fundamentals
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
Via StockStory · August 14, 2026
Herbalife Q2 Earnings Call Highlightsmarketbeat.com
Herbalife (NYSE:HLF) reported second-quarter net sales of $1.3 billion, up 5.4% from a year earlier and at the high end of its guidance range, as the nutrition company recorded its fourth consecutive quarter of year-over-year sales growth. On a constant-currency basis, net sales rose 5.8%, exceedin
Via MarketBeat · August 8, 2026
1 Small-Cap Stock Worth Your Attention and 2 We Brush Off
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...
Via StockStory · August 7, 2026
Herbalife (NYSE:HLF) Beats Q2 CY2026 Sales Expectations
Health and wellness products company Herbalife (NYSE:HLF) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 5.4% year on y...
Via StockStory · August 5, 2026
What To Expect From Herbalife’s (HLF) Q2 Earnings
Health and wellness products company Herbalife (NYSE:HLF) will be announcing earnings results this Wednesday after market hours. Here’s what you need to know...
Via StockStory · August 3, 2026
3 Cash-Producing Stocks Walking a Fine Line
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via StockStory · July 27, 2026
Personal Care Q1 Earnings: USANA (NYSE:USNA) Simply the Best
Let’s dig into the relative performance of USANA (NYSE:USNA) and its peers as we unravel the now-completed Q1 personal care earnings season. While personal c...
Via StockStory · July 13, 2026
2 Mooning Stocks Worth Investigating and 1 We Avoid
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...
Via StockStory · July 9, 2026
Inter Parfums, Estée Lauder, and Herbalife Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after President Trump declared the Iran ceasefire "over" and threatened more strikes. Staples...
Via StockStory · July 8, 2026
2 Reasons to Watch HLF and 1 to Stay Cautious
Over the past six months, Herbalife’s stock price fell to $12.16. Shareholders have lost 14.3% of their capital, which is disappointing considering the S&P 5...
Via StockStory · June 24, 2026
2 Stocks Under $50 with Promising Prospects and 1 Facing Headwinds
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline...
Via StockStory · June 17, 2026
2 Small-Cap Stocks for Long-Term Investors and 1 That Underwhelm
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...
Via StockStory · June 9, 2026
2 of Wall Street’s Favorite Stocks with Promising Prospects and 1 We Turn Down
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
Via StockStory · June 8, 2026
Chief Commercial Officer Sells 143,000 Shares of Herbalife for $1.9 Millionchief-com
Known for its global nutrition products and direct-selling model, this wellness firm reported a significant insider sale in recent filings.
Via The Motley Fool · June 3, 2026
Unpacking Q1 Earnings: Herbalife (NYSE:HLF) In The Context Of Other Personal Care Stocks
Let’s dig into the relative performance of Herbalife (NYSE:HLF) and its peers as we unravel the now-completed Q1 personal care earnings season. While persona...
Via StockStory · May 28, 2026
Q1 Earnings Highlights: Coty (NYSE:COTY) Vs The Rest Of The Personal Care Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
Via StockStory · May 13, 2026
The 5 Most Interesting Analyst Questions From Herbalife’s Q1 Earnings Call
Herbalife’s first quarter saw revenue and non-GAAP earnings per share come in above Wall Street expectations, but the market responded negatively due to conc...
Via StockStory · May 13, 2026
United Natural Foods Stock Is Up 85%. One Investor Just Sold Out Completelyfool.com
United Natural Foods distributes natural, organic, and conventional groceries to a wide range of North American retailers.
Via The Motley Fool · May 12, 2026
What to Know About This Fund’s Sale of a Pharma Stock Up 56% in a Yearfool.com
Supernus Pharmaceuticals delivers specialty therapies for CNS disorders, targeting healthcare providers and specialty pharmacies nationwide.
Via The Motley Fool · May 12, 2026
This $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116%fool.com
10x Genomics provides advanced tools for single cell and spatial biology research, serving academic and biopharma institutions worldwide.
Via The Motley Fool · May 12, 2026